Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Handa

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|February 1, 2003
Low dose methotrexate and bone marrow suppressionMichael Sosin, Sunil Handa
Journal of Clinical Pathology|August 28, 2012
Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK studySeetharam Anandram, Lakhvir Kaur Assi, Tracy Lovatt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 25, 2006
Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agentAbraham Jacob, Kanwaljit Sandhu, Johann Nicholas, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|February 1, 2003
Low dose methotrexate and bone marrow suppressionMichael Sosin, Sunil Handa
Journal of Clinical Pathology|August 28, 2012
Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK studySeetharam Anandram, Lakhvir Kaur Assi, Tracy Lovatt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 25, 2006
Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agentAbraham Jacob, Kanwaljit Sandhu, Johann Nicholas, et al.
Pageof 1